The GAVI Alliance was founded in 2000 by the Bill & Melinda Gates Foundation, the World Bank, the WHO, UNICEF and vaccine manufacturers, including Sanofi Pasteur, Pfizer, MSD, GSK, Novartis, and Crucell, subsidiary of Johnson & Johnson. Committed to saving children’s lives and protecting people’s health through the widespread use of vaccines, GAVI’s driving objective is to make a critical contribution to global immunization goals by supporting immunization programs and health systems, and accelerating the introduction of new vaccines.
Industry partners invest in the development of new vaccines and in enhanced global vaccine manufacturing capacity, including facilities in developing countries. They also help to educate healthcare providers and develop technologies to facilitate vaccine distribution.
GAVI addresses three critical gaps in the provision of vaccines:
GAVI supports new and underused vaccines, health system strengthening, immunization services, injection safety and civil society organizations In total, GAVI has committed USD 7.2 billion since 2000. Eighty (80) percent has been committed towards the purchase of vaccines. The GAVI Fund provides financial support to low-income countries, based upon applications to and recommendations by the GAVI Alliance Board. Besides, industry partners invest in the development of new vaccines and in enhanced global vaccine manufacturing capacity, including facilities in developing countries. They also help to educate healthcare providers and develop technologies to facilitate vaccine distribution.
Between 2000 and 2008, programs within the GAVI Alliance made it possible to immunize 213 million children, which represent at least 3.4 million lives saved. By the end of 2013, GAVI had supported the immunization of 400 million additional children, who might not otherwise have had access to vaccines, and prevented over 6 million future deaths.
GAVI-supported vaccine campaigns have resulted in a further 100 million individuals being immunised against meningitis A and 68 million against yellow fever since 2000. The offensive also targets the world’s two biggest child killers, pneumonia and diarrhea. GAVI has the potential to immunize 250 million children by 2015 and prevent another four million future deaths.
|Location||Eastern Europe, Central Africa, Central Asia, East Asia and Pacific, Eastern Africa, Latin America and Caribbean, South Asia, Southern Africa, West Africa, Afghanistan, Albania, Angola, Armenia, Bangladesh, Bhutan, Bolivia, Bosnia and Herzegovina, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, China, Comoros, Congo, The Republic of, Cote d Ivoire, Cuba, Djibouti, Eritrea, Ethiopia, Gambia, Georgia, Ghana, Guinea, Guinea-Bissau, Haiti, Honduras, India, Indonesia, Kenya, Kiribati, Kyrgyzstan, Lesotho, Madagascar, Malawi, Mali, Mauritania, Moldova, Monaco, Mozambique, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Senegal, Sierra Leone, Solomon Islands, Somalia, Sri Lanka, Sudan, Tajikistan, Tanzania, Togo, Turkmenistan, Uganda, Ukraine, Uzbekistan, Viet Nam, Yemen|